Rho GTPases as therapeutic targets in cancer (Review).

Rho GTPases as therapeutic targets in cancer (Review).
复制标题

DOI:
10.3892/ijo.2017.4093
复制
发表时间:
2017-10
影响因子:
5.2
通讯作者:
Gomez DE
Gomez DE
中科院分区:
医学2区
文献类型:
--
作者:
Cardama GA;Gonzalez N;Maggio J;Menna PL;Gomez DE

文献摘要

参考文献

被引文献

相似文献

Rho gtpase是控制外部信号向细胞质和细胞核效应器转导的关键分子开关。在过去的几年里,遗传和药理学工具的发展使得Rho GTPases在癌症中的具体作用有了更精确的定义。本综述的目的是描述这些蛋白调控的细胞功能,重点是在恶性肿瘤中存在的失调信号。最后,我们描述了以Rho GTPases为分子靶点的不同实验治疗策略的研究现状。
Rho GTPases are key molecular switches controlling the transduction of external signals to cytoplasmic and nuclear effectors. In the last few years, the development of genetic and pharmacological tools has allowed a more precise definition of the specific roles of Rho GTPases in cancer. The aim of the present review is to describe the cellular functions regulated by these proteins with focus in deregulated signals present in malignant tumors. Finally, we describe the state of the art in search of different experimental therapeutic strategies with Rho GTPases as molecular targets.
Formin MDIA2独立于其肌动蛋白成核活性稳定微管。
DOI: 10.1083/jcb.200709029
发表时间: 2008-05-05
影响因子: 7.8
作者:
Bartolini, Francesca;Moseley, James B.;Schmoranzer, Jan;Cassimeris, Lynne;Goode, Bruce L.;Gundersen, Gregg G.
通讯作者: Gundersen, Gregg G.
DOI: 10.1158/1535-7163.mct-13-0164
发表时间: 2013-10
影响因子: 5.7
作者:
Bid HK;Roberts RD;Manchanda PK;Houghton PJ
通讯作者: Houghton PJ
DOI: 10.1016/j.drudis.2010.06.011
发表时间: 2010-08
影响因子: 7.4
作者:
Dong, Ming;Yan, Bryan P.;Liao, James K.;Lam, Yat-Yin;Yip, Gabriel W. K.;Yu, Cheuk-Man
通讯作者: Yu, Cheuk-Man
DOI: 10.18632/oncotarget.10188
发表时间: 2016-08-09
期刊: Oncotarget
影响因子: --
作者:
Becker MS;Müller PM;Bajorat J;Schroeder A;Giaisi M;Amin E;Ahmadian MR;Rocks O;Köhler R;Krammer PH;Li-Weber M
通讯作者: Li-Weber M
DOI: 10.3892/or.2016.5094
发表时间: 2016-11-01
期刊: ONCOLOGY REPORTS
影响因子: 4.2
作者:
Armando, Romina G.;Mengual Gomez, Diego;Gomez, Daniel E.
通讯作者: Gomez, Daniel E.